Optimizing Clinical Indicators in Hematologic Malignancies and Sepsis Using ddPCR: A Retrospective Study
ddPCR outperforms BC in diagnostic efficiency for patients with HMs and sepsis, accelerating pathogen and AMR genes identification, optimizing antibacterial therapy and management, improving clinical effectiveness, and reducing 28-day all-cause mortality. The findings support the application of ddPCR in immunosuppressed populations.
Authors
- Yizhuo Liu (ORCID: https://orcid.org/0000-0002-4889-9698)
- Meiling Zhang (ORCID: https://orcid.org/0000-0002-1023-8827)
- Enhui Lv
- Chuanwei Xin (ORCID: https://orcid.org/0000-0001-5079-9090)
- Yuexing Tu (ORCID: https://orcid.org/0000-0003-3073-8746)
- Wenjuan Yang (ORCID: https://orcid.org/0000-0001-7270-8356)
- Yuxia Jiang
- Bei Zheng (ORCID: https://orcid.org/0000-0003-0575-1607)
- Huifang Jiang (ORCID: https://orcid.org/0000-0002-5049-4227)
Institutions
- Zhejiang Chinese Medical University (CN)
- Tongde Hospital of Zhejiang Province (CN)
- Zhe jiang Research Institute of Traditional Chinese Medicine (China) (CN)
- Hangzhou Hospital of Traditional Chinese Medicine (CN)
- Zhejiang Medicine (China) (CN)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1007/s40121-025-01207-1
- Citations
- 1
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Zhejiang Medical Association